COVID-19: Pentagon awards Glaxo $342 million contract for vaccines
The US Army will supervise execution of the project
Image Credit: AFP
Washington: The Pentagon on Thursday announced a $342 million (Dh1.2 billion) contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.
It said GSK was the only company to make a bid for the contract, which will consist of supporting "military locations and personnel throughout the continental US and outside the continental US."
ALSO SEE
- As COVID-19 shutters churches, tiny US chapel open for prayer
- COVID-19: Military jets fly over US cities to salute frontline workers
- Forgiato shows us what the new Corvette C8 looks like with its aftermarket wheels
- Tribute from the sky: US Fighter jets fly over New York to honour health workers battling coronavirus
The work will be carried out in North Carolina "with an estimated completion date of Feb. 28, 2021," the Pentagon said.
The US Army will supervise execution of the project.